Vericel Corp
VCEL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000887359
In the last 90 days, Vericel Corp insiders filed 0 open-market purchases and 3 sales; 320 institutions reported holding it in 13F filings for Q2 2026, worth $2.47B in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Vericel Corp as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 202
- −3 vs. Q2 2021
- Shares held
- 50.7M
- +1.83M (+3.7%) vs. Q2 2021
- Total value
- $2.48B
- −$92.0M (−3.6%) vs. Q2 2021
- New holders
- 20
- 83 more added
- Sold out
- 23
- 71 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VCEL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 320 | $2.47B |
| Q1 2026 | 280 | $1.78B |
| Q4 2025 | 274 | $1.93B |
| Q3 2025 | 249 | $1.67B |
| Q2 2025 | 273 | $2.35B |
| Q1 2025 | 277 | $2.39B |
| Q4 2024 | 278 | $2.87B |
| Q3 2024 | 268 | $2.15B |
| Q2 2024 | 261 | $2.32B |
| Q1 2024 | 257 | $2.68B |
| Q4 2023 | 227 | $1.84B |
| Q3 2023 | 214 | $1.73B |
| Q2 2023 | 202 | $1.88B |
| Q1 2023 | 200 | $1.48B |
| Q4 2022 | 178 | $1.32B |
| Q3 2022 | 180 | $1.21B |
| Q2 2022 | 183 | $1.34B |
| Q1 2022 | 197 | $2.01B |
| Q4 2021 | 185 | $2.04B |
| Q3 2021 | 202 | $2.48B |
| Q2 2021 | 205 | $2.57B |
| Q1 2021 | 205 | $2.75B |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Vericel Corp; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FourThought Financial, LLC | 12 | $1.00K | 0.00% | 00.0% | Unchanged |
| Berman Capital Advisors, LLC | 17 | $0 | 0.00% | +14+466.7% | Added |
| Artisan Partners Limited Partnership | 0 | $0 | 0.00% | −600,397−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −37,787−100.0% | Sold out |
| Advisory Research Inc | 0 | $0 | 0.00% | −19,911−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −12,786−100.0% | Sold out |
| Twinbeech Capital LP | 0 | $0 | 0.00% | −11,738−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −10,709−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −10,400−100.0% | Sold out |
| Old Mission Capital LLC | 0 | $0 | 0.00% | −10,301−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −8,447−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −7,611−100.0% | Sold out |
| Abacus Planning Group, Inc. | 0 | $0 | 0.00% | −6,020−100.0% | Sold out |
| Guggenheim Capital LLC | 0 | $0 | 0.00% | −5,947−100.0% | Sold out |
| Citizens Financial Group Inc | 0 | $0 | 0.00% | −5,065−100.0% | Sold out |
| Eqis Capital Management, Inc. | 0 | $0 | 0.00% | −4,843−100.0% | Sold out |
| Capula Management Ltd | 0 | $0 | 0.00% | −4,206−100.0% | Sold out |
| Sawgrass Asset Management LLC | 0 | $0 | 0.00% | −4,030−100.0% | Sold out |
| Altshuler Shaham Ltd | 0 | $0 | 0.00% | −1,879−100.0% | Sold out |
| Carroll Financial Associates, Inc. | 0 | $0 | 0.00% | −965−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Harbour Investments, Inc. | 0 | $0 | 0.00% | −179−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| McCarthy Asset Management, Inc. | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| Sofos Investments, Inc. | 0 | $0 | 0.00% | −55−100.0% | Sold out |